<DOC>
	<DOCNO>NCT02808390</DOCNO>
	<brief_summary>This Phase 2 , multicenter , randomize , double-blind , placebo-controlled , parallel-group study evaluate efficacy safety 2 dose GED-0507-34-Levo subject active , mild-to-moderate UC .</brief_summary>
	<brief_title>Efficacy Safety Study GED-0507-34-Levo Treatment UC</brief_title>
	<detailed_description>This Phase 2 , Proof Concept , multicenter , randomize , double-blind , placebo-controlled , parallel-group study evaluate efficacy safety 2 dose GED-0507-34-Levo subject active , mild-to-moderate Ulcerative Colitis . The study consist 3 phase : - Screening Phase - 4 week - Double-blind Placebo-controlled Phase - Weeks 0 8 - Follow-up Phase - Week 9</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<criteria>Male female age 18 time signing informed consent . Diagnosis UC duration least 3 month prior Screening Visit . MMS ≥ 4 ≤ 8 ( range : 0 9 ) prior randomization study Subjects require colonoscopy one perform within 12 month prior Screening Visit . Subjects relapse maintenance therapy dose 5ASA &lt; 2.4 g/day Diagnosis Crohn 's disease , indeterminate colitis , ischemic colitis , microscopic colitis , radiation colitis , diverticular diseaseassociated colitis . UC restrict distal 15 cm less ( eg , ulcerative proctitis ) . Subjects surgery treatment UC , opinion Investigator , likely require surgery UC study . Clinical sign suggestive fulminant colitis toxic megacolon . Evidence pathogenic enteric infection . History colorectal cancer colorectal dysplasia . Prior use TNF inhibitor ( biologic agent ) . Prior use mycophenolic acid , tacrolimus , sirolimus , cyclosporine , thalidomide . Use budesonideMMx within last 8 week . Use oral and/or IV corticosteroid within 2 week Screening Visit . Use immunosuppressant ( azathioprine [ AZA ] , 6mercaptopurine [ 6MP ] methotrexate [ MTX ] ) within 8 week Screening Visit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>